| |
| |
|
| Insider
Information: |
Sablich Kim |
| Relationship: |
|
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
181,188 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,070,027 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
181,188 |
|
|
| Total
Value |
$7,070,027 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 243.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Myovant Sciences Ltd. |
MYOV |
Chief Commercial Officer |
2020-04-03 |
146,710 |
2018-12-17 |
0 |
Premium* |
|
|
Jazz Pharmaceuticals Inc |
JAZZ |
EVP, GM of U.S. |
2023-06-05 |
28,478 |
2020-08-06 |
0 |
Premium* |
|
|
Celladon Corp |
CLDN |
|
2022-03-11 |
6,000 |
2022-03-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP, GM of U.S. |
• – – |
2023-06-05 |
4 |
D |
$129.73 |
$270,098 |
D/D |
(2,082) |
28,478 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP, GM of U.S., Commercial Ma |
• – – |
2023-03-08 |
4 |
AS |
$139.42 |
$421,043 |
D/D |
(3,013) |
30,560 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP, GM of U.S., Commercial Ma |
• – – |
2023-03-05 |
4 |
D |
$142.78 |
$229,876 |
D/D |
(1,610) |
33,573 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP, GM of U.S., Commercial Ma |
• – – |
2023-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
10,429 |
35,183 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & GM, North America |
• – – |
2022-06-07 |
4 |
AS |
$148.21 |
$368,714 |
D/D |
(2,441) |
24,754 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & GM, North America |
• – – |
2022-06-06 |
4 |
D |
$149.25 |
$262,531 |
D/D |
(1,759) |
28,583 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & GM, North America |
• – – |
2022-06-06 |
4 |
AS |
$152.15 |
$211,184 |
D/D |
(1,388) |
27,195 |
0 |
- |
|
| CLDN |
Celladon Corp |
|
• • – |
2022-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & GM, North America |
• – – |
2022-03-05 |
4 |
D |
$153.96 |
$114,854 |
D/D |
(746) |
30,342 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & GM, North America |
• – – |
2022-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
9,953 |
31,088 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & GM, North America |
• – – |
2021-11-11 |
4 |
S |
$135.01 |
$371,000 |
D/D |
(2,748) |
21,135 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & GM, North America |
• – – |
2021-06-05 |
4 |
D |
$176.47 |
$256,234 |
D/D |
(1,452) |
23,883 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & GM, North America |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
8,535 |
25,335 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & GM, North America |
• – – |
2020-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
16,800 |
16,800 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Commercial Officer |
• – – |
2020-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
87,805 |
146,710 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Commercial Officer |
• – – |
2020-03-18 |
4 |
S |
$6.93 |
$5,787 |
D/D |
(785) |
58,905 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Commercial Officer |
• – – |
2020-01-15 |
4 |
AS |
$14.04 |
$67,954 |
D/D |
(4,840) |
59,690 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Commercial Officer |
• – – |
2019-12-18 |
4 |
S |
$16.22 |
$41,929 |
D/D |
(2,585) |
64,530 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Commercial Officer |
• – – |
2019-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
37,415 |
67,115 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Commercial Officer |
• – – |
2018-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
29,700 |
29,700 |
0 |
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
